This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeMaster, E.
Right arrow Articles by Cleary, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeMaster, E.
Right arrow Articles by Cleary, P.

 Previous Article  |  Next Article 

Infection and Immunity, January 2002, p. 350-359, Vol. 70, No. 1
0019-9567/01/$04.00+0     DOI: 10.1128/IAI.70.1.350-359.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

M+ Group A Streptococci Are Phagocytized and Killed in Whole Blood by C5a-Activated Polymorphonuclear Leukocytes

Eric DeMaster,1 Norbert Schnitzler,2 Qi Cheng,1 and Patrick Cleary1*

Department of Microbiology, University of Minnesota, Minneapolis, Minnesota,1 Institute of Medical Microbiology and National Reference Laboratory for Streptococci, University Hospital, Aachen, Germany2

Received 6 August 2001/ Returned for modification 26 September 2001/ Accepted 10 October 2001

Historically, resistance to phagocytosis has been determined by incubating group A streptococci in human blood and comparing the numbers of CFU before and after incubation. Utilizing a flow cytometry-based technique, we have investigated the phagocytosis of M+ group A streptococci by polymorphonuclear leukocytes (PMNs) in heparinized human peripheral whole blood. Intracellular labeling of streptococci with a nontoxic fluorescent dye allowed us to quantify the association and phagocytosis of M+ streptococci by PMNs in whole blood in the presence or absence of C5a, a physiologically important chemotactic activator of PMNs. We found that wild-type strains of group A streptococci that are resistant to phagocytosis (determined by the classical Lancefield method) readily associate with C5a-activated whole-blood PMNs. In the absence of opsonizing M-type-specific antibodies, the M+ streptococci associated with PMNs are phagocytized and killed. In addition, blockade of the ß2 integrin, CD11b/CD18, with anti-human CD11b monoclonal antibody inhibited association between M+ streptococci and C5a-activated PMNs. These findings establish a new relationship between M+ streptococci and PMNs, in which C5a-activated PMNs have the capacity to kill M+ streptococci in whole blood through a receptor-mediated phagocytic mechanism.


* Corresponding author. Mailing address: Department of Microbiology, University of Minnesota, Minneapolis, MN 55455. Phone: (612) 624-6190. Fax: (612) 626-0623. E-mail: cleary{at}lenti.med.umn.edu.

Editor: T. R. Kozel


Infection and Immunity, January 2002, p. 350-359, Vol. 70, No. 1
0019-9567/01/$04.00+0     DOI: 10.1128/IAI.70.1.350-359.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Terao, Y., Yamaguchi, M., Hamada, S., Kawabata, S. (2006). Multifunctional Glyceraldehyde-3-phosphate Dehydrogenase of Streptococcus pyogenes Is Essential for Evasion from Neutrophils. J. Biol. Chem. 281: 14215-14223 [Abstract] [Full Text]  
  • Weineisen, M., Sjobring, U., Fallman, M., Andersson, T. (2004). Streptococcal M5 Protein Prevents Neutrophil Phagocytosis by Interfering with CD11b/CD18 Receptor-Mediated Association and Signaling. J. Immunol. 172: 3798-3807 [Abstract] [Full Text]  
  • Mollnes, T. E., Brekke, O.-L., Fung, M., Fure, H., Christiansen, D., Bergseth, G., Videm, V., Lappegard, K. T., Kohl, J., Lambris, J. D. (2002). Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100: 1869-1877 [Abstract] [Full Text]